APA

Byrnes V. W., Emini E. A., Schleif W. A., Condra J. H., Schneider C. L., Long W. J., Wolfgang J. A., Graham D. J., Gotlib L. & Schlabach A. J. (19941017). Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. : Antimicrobial agents and chemotherapy.

Chicago

Byrnes V W, Emini E A, Schleif W A, Condra J H, Schneider C L, Long W J, Wolfgang J A, Graham D J, Gotlib L and Schlabach A J. 19941017. Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. : Antimicrobial agents and chemotherapy.

Harvard

Byrnes V. W., Emini E. A., Schleif W. A., Condra J. H., Schneider C. L., Long W. J., Wolfgang J. A., Graham D. J., Gotlib L. and Schlabach A. J. (19941017). Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. : Antimicrobial agents and chemotherapy.

MLA

Byrnes V W, Emini E A, Schleif W A, Condra J H, Schneider C L, Long W J, Wolfgang J A, Graham D J, Gotlib L and Schlabach A J. Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. : Antimicrobial agents and chemotherapy. 19941017.